Medipattern's B-CAD(R) Increases Diagnostic Accuracy on Small Breast Cancer Lesions

The Medipattern Corporation (TSX VENTURE:MKI - News), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that a study abstract, showing a statistically significant increase in diagnostic accuracy when using B-CAD Version 2 on lesions less than 1 cm in size, has been published in the October 2008 issue of the American Journal of Clinical Oncology.

The study was conducted at the PLA301 Hospital in Beijing, China using the global version of B-CAD Version 2, and reported in the paper: "The Value of Computer-Aided Detection for Breast Ultra-Sonography (B-CAD) in the Diagnosis of Breast Cancer" by principal authors Dr. Jun Lai Li and Dr. Dan Fei Song. The study is based upon 100 confirmed biopsied cases, comparing the diagnostic accuracy of three reading scenarios: a single physician, double reading with two physicians, and a single physician reading with B-CAD. The accuracy of the single physician increased with B-CAD in all categories. The most striking result shows a statistically significant 44 percent improvement in diagnostic accuracy for the single reader with B-CAD V2 on lesions less than 1 cm in size (n equals 9).

source: Medipattern